Results 121 to 130 of about 244,777 (197)

Molecular subtypes and the (in vitro) response of glioblastoma to temozolomide. [PDF]

open access: yesBJC Rep
Rancati S   +10 more
europepmc   +1 more source

Biomarkers for predicting immunotherapy response and resistance in glioblastoma. [PDF]

open access: yesFront Immunol
Kim S   +4 more
europepmc   +1 more source

Identification of drug candidates against glioblastoma with machine learning and high-throughput screening of heterogeneous cellular models.

open access: yesDigit Discov
Smer-Barreto V   +7 more
europepmc   +1 more source

Novel CAR T cell blend targeting PDPN and GD2 to overcome glioblastoma heterogeneity. [PDF]

open access: yesJ Immunother Cancer
Hübner J   +18 more
europepmc   +1 more source

Thin Glomerular Basement Membrane Phenotypes With No Identified Pathogenic <i>COL4A3/A4/A5</i> Variant. [PDF]

open access: yesKidney Int Rep
Riella CV   +15 more
europepmc   +1 more source

Hsa-miR-25-3p Inhibition Sensitizes Patient-Derived Glioblastoma Cells to Temozolomide via β-catenin Downregulation. [PDF]

open access: yesCell Mol Neurobiol
Richter K   +11 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy